ロード中...
Targeting the Ras pathway in pediatric hematologic malignancies
PURPOSE: Ras pathway mutations are one of the most common type of alterations in pediatric hematologic malignancies and are frequently associated with adverse outcomes. Despite ongoing efforts to use targeted treatments, there remain no food and drug administration (FDA) approved medications specifi...
保存先:
| 出版年: | Curr Opin Pediatr |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7880552/ https://ncbi.nlm.nih.gov/pubmed/33394740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOP.0000000000000981 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|